Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | PARL | Q9H300 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133554 | 0.89 | KMT2A (0.53) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL19309377 | 0.89 | KMT2A (0.53) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL15169077 | 0.83 | KMT2A (0.48) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL15169078 | 0.83 | KMT2A (0.48) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL76714 | 0.83 | KMT2A (0.48) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL300884 | 0.80 | CA12 (0.42) | MGLLKMT2ALMNAMAPK1PARL | |
| SCHEMBL4872950 | 0.80 | SMN1; SMN2 (0.54) | MGLLKMT2AMAPK1PARLMAPT | |
| SCHEMBL20027226 | 0.78 | KMT2A (0.47) | MGLLKMT2ALMNAF2MAPK1 | |
| SCHEMBL29065830 | 0.77 | PARL (0.48) | MGLLKMT2AMAPK1PARLALOX12 | |
| SCHEMBL27717830 | 0.77 | CA1 (0.55) | MGLLKMT2ATSHRMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016205144-A1 | COMPOSITIONS OF PLATELET-DERIVED THERANOSTICS AND USES THEREOF | BLUECIRCLE THERAPEUTICS, INC. (US) | 2016-12-22 | — | — | WO | disclosed |
| US-20120046451-A1 | ANTI-lgSF4 ANTIBODY AND UTILIZATION OF THE SAME | INSTITUTE FOR ANTIBODIES CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-8048992-B2 | Anti-IgSF4 antibody and utilization of the same | INSTITUTE FOR ANTIBODIES CO., LTD. (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-1860119-B1 | ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME | INST ANTIBODIES CO LTD (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-7776538-B2 | Method for diagnosing methamphetamine dependence | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20090155778-A1 | Mental Disorder-Related Gene and Use of the Same | NATIONAL UNIVERSITY CORPORATION NAGOYA (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090053243-A1 | Anti-IgSF4 Antibody and Utilization of the Same | INSTITUTE FOR ANTIBODIES CO., LTD (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1860119-A1 | ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME | Institute for Antibodies Co., Ltd. (JP) | 2007-11-28 | — | — | EP | disclosed |
| US-20060194268-A1 | Method for measuring spinorphin | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2006-08-31 | — | — | US | disclosed |